ERBB2 and cancer: The positive correlation between the presence of ERBB2 focal amplifications in GCA and patient prognosis is paradoxical to large-scale TCGA studies in many cancer types7, where the presence of ecDNA amplicons was shown to be associated with poor outcomes.